Impact

“Over the past eight years, USAID has leveraged over $6.7 billion in donated medicines [for its NTD control program, of which the END program is a part], reflecting one of the most cost-effective public health programs. Because of this support, we are beginning to document control and elimination of these diseases in our focus countries and we are on track to meet the 2020 goals.”

Dr. Ariel Pablos-Mendez, Assistant Administrator for USAID’s Global Health Bureau, May 8, 2014, Washington, DC.

Photo Credit: FHI 360


 

NTD treatments lower disease risks for tens of millions

While there’s still a long way to go before declaring victory on NTDs, END in Africa has helped tens of millions of people who had been at high risk for contracting lymphatic filariasis and blinding trachoma. This means that millions no longer have to worry that they or their loved ones will go blind or suffer from painful, swollen limbs. It means they can continue working and taking care of their families and their children can continue going to school. It means hope, stronger families, healthier communities, and a much better chance for a high quality of life.

Photo Credit: Hellen Keller International

Number of people no longer at high risk for LF*

32.3 Million

* FY 2016 data

Number of people no longer at high risk for blinding trachoma*

22.5 Million

* FY 2016 data